| CXSL2400251 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2024-04-20 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSS2400038 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2024-04-08 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSB2300093 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(原1) | Supplementary Application | 2023-08-29 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSL2300120 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2023-02-11 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CYSB2200009 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(原1) | Supplementary Application | 2022-01-10 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSS2101085 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2021-12-24 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSB2101067 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(原1) | Supplementary Application | 2021-12-20 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSS2101045 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2021-11-04 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CYSB2101226 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(1) | Supplementary Application | 2021-10-19 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSS2101031 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2021-09-22 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CYSB2101178 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(原1) | Supplementary Application | 2021-09-06 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSL2101074 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2021-05-14 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSL2101032 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2021-04-23 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSS2100009 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2021-01-13 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2021-01-12 | view |
| CXSS2100007 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2021-01-13 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2021-11-05 | view |
| CXSB2100002 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(原1) | Supplementary Application | 2021-01-06 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2021-09-02 | view |
| CXSS2000043 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2020-08-20 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-08-19 | view |
| CXSL2000234 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2020-08-12 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-08-11 | view |
| CXSL2000232 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2020-08-12 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-08-11 | view |
| CXSL2000223 | 信迪利单抗注射液 | sintilimab | Injection | Biological Products(2.2) | New Drug Application | 2020-08-04 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2020-08-03 | view |
